Deutsch
Wissenschaftliche Studien Cannabisverdampfung
- Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users
T. R. Spindle et al., United States (April 2020) -
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
T. van de Donk et al., Netherlands (Dezember 2018) - Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis
T. R. Spindle et al., United States (November 2018) - Cannabis use and driving-related performance in young recreational users: a within-subject randomized clinical trial
T. Ogourtsova et al., Canada (September 2018) - Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting
N. Solowij et al., Australia (Januar 2018) - Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
B. Wilsey et al., United States (Oktober 2012) - CB 1 Binding Activity and Quantitative Analysis of Cannabis
J.T. Fischedick, F. van der Koy and R. Verpoorte, Netherlands (November 2009) - Cannabis smoke condensate III: the cannabinoid content of vaporised Cannabis sativa
B. Pomahacova, F. Van der Kooy, and R. Verpoorte, Netherlands (November 2009) - Cannabis smoke condensate II: influence of tobacco on tetrahydrocannabinol levels
F. Van der Kooy, B. Pomahacova, and R. Verpoorte, Netherlands (Februar 2009) - Effect of intrapulmonary tetrahydrocannabinol administration in humans
L. Zuurman et al., Netherlands (Mai 2008) - Vaporization as a smokeless cannabis delivery system: a pilot study
Prof. D. Abrams et al., United States (April 2007) - A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9-tetrahydrocannabinol (THC) by vaporisation
D. Gieringer et al., United States (Oktober 2004)
